In prostate cancer (PCa), ERα positivity inhibits CCL5 expression in cancer-associated fibroblasts (CAFs), leading to reduced macrophage infiltration, migration of M2 macrophages, and inhibition of prostate cancer invasion (24). Here, CCL5 is linked to prostate carcinoma.